We cordially invite you to attend the 9/30 UCSF Center for Translational and Personalized Medicine (TRANSPERS) Symposium to learn about our work on personalized/precision medicine, particularly our new NIH-funded study on benefit-risk tradeoffs for whole genome sequencing from a health care policy perspective.
The kick-off and dinner sessions will discuss the benefit-risk tradeoffs of whole genome sequencing (WGS) from the perspectives of patients, providers, the health care delivery system, and society. Our featured dinner speaker is Robert Green MD MPH, Harvard Medical School, who is the PI of the first randomized clinical trial of whole genome sequencing into clinical medicine (MedSeq Study). TRANSPERS is conducting a study, collaboratively with MedSeq, to examine preferences, reimbursement, and value of WGS.
The Symposium brings together three groups – TRANSPERS collaborators, our Scientific Advisory Board, and our Evidence and Reimbursement Council - composed of senior executives from the seven largest private health plans in the U.S., regional plans, and thought leaders with industry, government, and Medicare perspectives.
Please RSVP, indicating which session(s) you attend, by Sept 16 to TRANSPERSInfo@ucsf.edu.
4-5PM Kickoff: Benefit-Risk Trade-Offs for Whole Genome Sequencing: Perspectives of Patients, Providers, Health Plans, and Society. Speaker: Kathryn A. Phillips PhD UCSF, with closing remarks by Joe Guglielmo, Dean UCSF School of Pharmacy. Lange Library, Parnassus.
5:00-7:30PM Reception and Seminar: Updates on the Harvard MedSeq study – The First RCT of WGS vs. Standard of Care. Guest speaker: Robert C. Green MD MPH, Harvard Medical School, Lange Library, Parnassus (heavy appetizers and refreshments).
We also invite you to join us from 2-3:30 at UCSF Laurel Heights 416 for a special session on reimbursement and health reform issues for precision medicine and next generation tumor sequencing, with guest speakers including Pat Deverka MD MS MBE Senior Research Director at the Center for Medical Technology Policy, Baltimore, MD MBA and Julia Trosman PhD MBA Executive Frameworks.